WETS
JBIO

Wealth Enhancement Trust Services’s Jade Biosciences JBIO Stock Holding History

Wealth Enhancement Trust Services’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22 Buy
+1
New +$21 ﹤0.01% 1499

Other funds holding JBIO

DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
AFC
Ares Financial Consulting Calabasas, California $139M AUM
OCWP
Owl Creek Wealth Partners Denver, Colorado $342M AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Wealth Enhancement Trust Services's JBIO Position: Q2 2026 in Review

Wealth Enhancement Trust Services opened a new position in Jade Biosciences (JBIO) in Q2 2026: 1 share worth $22. The stake represents ﹤0.01% of the portfolio and ranks #1499 among its holdings.

14 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

  • Wealth Enhancement Trust Services held 1 share of Jade Biosciences worth $22 as of Q2 2026.
  • Jade Biosciences was a new Wealth Enhancement Trust Services position in Q2 2026.
  • Jade Biosciences made up ﹤0.01% of Wealth Enhancement Trust Services's portfolio in Q2 2026, its #1499 holding.
  • 14 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q2 2026, filed 15 Jul 2026.